News | Remote Viewing Systems | March 21, 2018

NucleusHealth Presents Cloud Medical Image Management Platform-as-a-Service at HIMSS

Nucleus.io delivers a web scale medical imaging and machine learning platform to share images through users’ own tools and specialty workflows

March 21, 2018 — Cloud-based medical image management and teleradiology company NucleusHealth recently announced the commercial licensing of its Platform-as-a-Service (Nucleus PaaS) that was showcased within the Microsoft booth at the Healthcare Information and Management Systems Society (HIMSS) Conference, March 5-9 in Las Vegas. Nucleus PaaS provides integration partners, across every facet of the healthcare industry, with medical imaging data at the speed and scalability of next-generation cloud technology, allowing third parties to deliver medical images through their own tools and specialty workflows.

"Many healthcare systems and companies have either developed or acquired clinical applications to deliver patient data to caregivers while they're remote or mobile," said President and Chief Operating Officer Claude Hooton. "However, the key data missing in these applications are current and prior diagnostic medical images (i.e. DICOM), which are critical for delivering superior patient care, enhancing various workflows, and even for creating new revenue opportunities," said Hooton.

Others in the healthcare industry also have a need to consume medical imaging data in areas such as planning applications for medical devices, for custom manufacturing of implants, for clinical research and tracking of clinical outcomes, and for product development. Nucleus PaaS enables cloud-based medical imaging integration to current clinical systems and to the third-party applications.

By leveraging Microsoft Azure, Nucleus PaaS can empower care teams and unleash new capabilities for the entire imaging ecosystem ranging from providers, medical device manufacturers, pharmaceutical companies and clinical SaaS application developers, to payors. Developers can take full advantage of the platform through a robust layer of RESTful application programming interface (APIs) to support clinical workflows and build custom web-based medical imaging applications much faster and easier. The solution also provides a means to extract greater value from data through advanced analytics and machine learning. Using Nucleus PaaS allows developers to create, test, manage, automate and update their unique apps without having to spend years building their web-based platform.

The Nucleus.io platform powers a complete suite of cloud-based imaging applications built on Nucleus PaaS, each developed to optimize interactions with medical images end-to-end, including diagnostic reading, archiving, image sharing and clinical viewing. Nucleus.io is scalable and enables secure remote access to any internet-enabled device, made possible with patented StatStream technology for immediate access to even the largest of medical images. Nucleus.io's client-side rendering techniques solve for latency with instant load times and a responsive user experience without loss of performance or image quality.

For more information: www.nucleushealth.io

 

Related Content

Sponsored Content | Videos | Mammography | January 24, 2020
Imaging Technology News Contributing Editor Greg Freiherr interviewed...
he U.S. Food and Drug Administration (FDA) has issued a final order to reclassify medical image analyzers applied to mammography breast cancer, ultrasound breast lesions, radiograph lung nodules and radiograph dental caries detection, postamendments class III devices (regulated under product code MYN), into class II (special controls), subject to premarket notification

Image courtesy of iCAD

News | Computer-Aided Detection Software | January 22, 2020
January 22, 2020 — The U.S.
Medical imaging technology company Oxipit announced partnership with Swiss medical distribution company Healthcare Konnect to bring ChestEye AI imaging suite to healthcare institutions in Nigeria
News | Artificial Intelligence | January 22, 2020
January 22, 2020 — Medical imaging technology company Oxipit ann
Hitachi Healthcare Americas announced that it will create a new dedicated research and development facility within its North American headquarters facility in Twinsburg, Ohio
News | Radiology Business | January 21, 2020
January 21, 2020 — Hitachi Healthcare Americas announced that it will create a new dedicated research and development
Sponsored Content | Videos | Enterprise Imaging | January 20, 2020
GE Healthcare's iCenter is a cloud-based management software that provides 24/7 visibility to customers' visual and o
Konica Minolta Business Solutions, U.S.A., Inc. (Konica Minolta) announced its status as a Google Cloud Premier Partner.
News | Archive Cloud Storage | January 14, 2020
January 14, 2020 — ...
This is artificial intelligence on Fujifilm's mobile digital radiography system to immediately detect pneumothorax (a collapsed lung) and show the location to the technologist and attending physician in a unit before the image is even uploaded to the PACS for a read. AI applications like this that have immediate impact on critical patient care saw a lot of interest at RSNA 2019.

This is work-in-progress artificial intelligence app on Fujifilm's mobile digital radiography system to immediately detect pneumothorax (a collapsed lung), The AI highlights the area of interest to show the location to the technologist and attending physician in a unit before the image is even uploaded to the PACS for a read by a radiologist. The technology also can flag the study for an immediate read in the PACS worklist for confirmation by a human. This technology is from a third-party and will be offered on Fujifilm's REiLI AI platform. Applications like this that have immediate impact on critical patient care saw a lot of interest at RSNA 2019. Photos by ITN Editor Dave Fornell.

Feature | Artificial Intelligence | December 27, 2019 | Siddharth Shah and Srikanth Kompalli, Frost & Sullivan
Radiology artificial intelligence (AI) was again the hottest topic at the 2019...